Appendix 1: Assessment Collaboration Framework - Canada-United States Rolling Workplan

Regulatory areas of focus

The United States (U.S.) Environmental Protection Agency and Environment and Climate Change Canada and Health Canada are working together to advance risk assessment activities in the following areas:

1. Information sharing
Area of focus Timeline Expected outcome/result Status
a) Data gathering activities December 2017 to December 2018
  • Crosswalk of recent and planned data gathering activities
  • Sharing of respective approaches for data gathering
b) Environmental monitoring data December 2017 to December 2018
  • Exchange of list of substances for which environmental media data is available
  • Exchange of respective datasets for substances of interest to the other jurisdiction
2. Priority setting activities
Area of focus Timeline Expected outcome/result Status
a) Examination of previously used priority approaches / lessons learned December 2017
  • Canada and U.S. analysis of priority setting approaches and lessons learned
  • Collaboration on planned project on lessons learned on best practices on Priority Setting within the OECD
b) Stakeholder consultation on priority setting December 2017 to May 2018
  • Participate in discussions/workshops on priority setting activities
3. Data evaluation
Area of focus Timeline Expected outcome/result Status
a) Data capture and storage mechanisms September 2017
  • Sharing IUCLID guidance (September 2017)
–  December 2017 to December 2018
  • Through representation on OECD IUCLID Expert User Group, support enhacements to IUCLID
b) Data evaluation / review (e.g. training, template development; exposure and/or hazard) September 2017
  • Participation in respective initatives including Canada’s particpation in the U.S. Systematic Review Webinar (September 2017)
  • Canada to give a webinar to U.S. on robust study summary template used to assess environmental fate and toxicity data
  • Canada to share with U.S. robust study summaries for chemicals that are of interest to U.S.
4. Risk assessment approaches/methodology for existing and new chemicals
Area of focus Timeline Expected outcome/result Status
a) Strengthening / developing chemical categories Fall 2017 to ongoing
  • Updating and refining current chemical categories considering new approach methodology
b) Sharing risk assessment guidance and tools /approaches TBD
  • Sharing crosswalk of existing risk assessment guidance and tools/approaches; including presentations on those tools and approaches unique to one jurisdiction
  • Development of Expert Group(s), as appropriate
c) Collaboration on emerging tools/approaches, including alternatives to animal testing October 2017
  • Participate in October 2017 launch of the Canadian Centre for Alternatives to Animal Methods (CCAAM)
November 2017
  • Participation in November 2017 US workshop on alternatives to animal testing
By June 2018
  • Canada to input to U.S. Strategic Plan on alternatives to animal testing
d) Inter-agency peer review/consultation on risk assessment approaches / methodology TBD
  • Peer review of Canadian nanotechnology framework
  • Peer review of Strategic Plan on alternatives to animal testing
5. Risk assessment work sharing
Area of focus Timeline Expected outcome/result Status
a) Analysis of common forward priorities January 2018
  • Updated crosswalk of common priorities
b) Existing chemicals December 2019
  • N-Methylpyrrolidone (NMP)
December 2018
  • Exploring opportunities for work sharing on 1-bromopropane
c) Inter-agency peer review of risk assessments TBD TBD
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: